Stocks
Arcturus Therapeutics Holdings (ARCT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 321% | 5 102% | 1 912% | 3 758% | 8 167% | ||||
| Changes by years, y/y, % | -792pp | +1 781pp | -3 189pp | -1 912pp | +26.7% | ||||
Arcturus Therapeutics Holdings. R&D/CAPEX, %
Arcturus Therapeutics Holdings. R&D/CAPEX, changes, pp
Arcturus Therapeutics Holdings (ARCT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 14 878% | 5 207% | 3 204% | 22 322% | 8 167% | |||
| Changes by years, y/y, % | +4 775pp | +3 483pp | -709pp | +2 495pp | +14 830pp | |||
| Changes by quarters, q/q, % | +7 386pp | -9 671pp | -5 207pp | +19 118pp | ||||
